[1]何闯,吴蔚,袁晶,等.CT引导下穿刺活检对ⅠA期非小细胞肺癌疾病无进展生存期和总生存期的影响[J].介入放射学杂志,2020,29(04):372-375.
 HE Chuang,WU Wei,YUAN Jing,et al. The influence of CT-guided needle biopsy on disease-free progressive survival and overall survival in patients with stage ⅠA non-small cell lung cancer[J].journal interventional radiology,2020,29(04):372-375.
点击复制

CT引导下穿刺活检对ⅠA期非小细胞肺癌疾病无进展生存期和总生存期的影响()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
29
期数:
2020年04
页码:
372-375
栏目:
非血管介入
出版日期:
2020-05-08

文章信息/Info

Title:
 The influence of CT-guided needle biopsy on disease-free progressive survival and overall survival in patients with stage ⅠA non-small cell lung cancer
作者:
何闯吴蔚袁晶陈玉潇杨丽李良山李廷源黄学全
Author(s):
HE Chuang WU Wei YUAN Jing CHEN Yuxiao YANG Li LI Liangshan LI Tingyuan HUANG Xuequan.
Department of Minimally-Invasive Intervention, First Affiliated Hospital of Army Medical University (Third Military Medical University), Chongqing 400038, China
关键词:
【关键词】 非小细胞肺癌ⅠA期活检
文献标志码:
A
摘要:
【摘要】 目的?探讨ⅠA期非小细胞肺癌(NSCLC)患者根治术术前活检是否影响患者的疾病无进展生存期(PFS)和总生存期(OS)。方法?回顾性收集2007—2014年行根治术的ⅠA期NSCLC患者225例,根据是否行CT引导下穿刺活检,依临床基本特征进行1∶1倾向性匹配分析(PSM),活检组和非活检组分别有47例纳入研究。采用Kaplan-Meier生存曲线和Cox回归分析进行生存分析。
结果?经PSM匹配后两组基本临床资料无显著差异。匹配后中位随访时间58.5个月,活检组和非活检组的PFS分别为(64.8±31.4)和(61.2±34.4)个月,两组PFS差异无统计学意义(χ2=0.020,P=0.888),OS分别为(67.9±30.2)、(65.3±31.3)个月,差异无统计学意义(χ2=0.003,P=0.955)。单因素和多因素分析显示根治术术前行CT引导下经皮穿刺活检不是患者PFS和OS的影响因素。结论?ⅠA期NSCLC术前行CT引导下经皮穿刺活检不影响患者的PFS和OS。

参考文献/References:

[1] National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med, 2011, 365: 395-409.
[2] 周清华, 范亚光, 王?颖, 等. 中国肺癌低剂量螺旋CT筛查指南(2018年版)[J]. 中国肺癌杂志, 2018, 21:67-75.
[3] Baldwin DR, Ten Haaf K, Rawlinson J, et al. Low dose CT screening for lung cancer[J]. BMJ, 2017, 359: j5742.
[4] 何?闯, 李?扬, 杨?丽, 等. CT 引导下肺实性结节切割活检术后出血与气胸的多因素分析[J]. 介入放射学杂志, 2017, 26:654-659.
[5] Yang L, Zhang Q, Bai L, et al. Assessment of the cancer risk factors of solitary pulmonary nodules[J]. Oncotarget, 2017, 8: 29318-29327.
[6] Ettinger DS, Wood DE, Aisner DL, et al. NCCN Clinical Practice Guidelines in Oncology: non-small cell lung cancer(version 5. 2017)[J].
J Natl Compr Canc Netw, 2017, 15: 504-535.
[7] Detterbeck FC, Boffa DJ, Kim AW, et al. The eighth edition lung cancer stage classification[J]. Chest, 2017, 151: 193-203.
[8] 范景丽, 翟可可, 任婷婷, 等. CT引导下穿刺活检对Ⅰ期~Ⅱ期非小细胞肺癌远处转移和生存的影响[J]. 中国肺癌杂志, 2017, 20:187-191.
[9] Struve-Christensen E. Iatrogenic dissemination of tumour cells. Dissemination of tumour cells along the needle track after percutaneous, transthoracic lung biopsy[J]. Dan Med Bull, 1978, 25: 82-87.
[10] Richardson CM, Pointon KS, Manhire AR, et al. Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies[J]. Br J Radiol, 2002, 75: 731-735.
[11] Tomiyama N, Yasuhara Y, Nakajima Y, et al. CT-guided needle biopsy of lung lesions: a survey of severe complication based on 9783 biopsies in Japan[J]. Eur J Radiol, 2006, 59: 60-64.
[12] Wang T, Luo L, Zhou Q. Risk of pleural recurrence in early stage lung cancer patients after percutaneous transthoracic needle biopsy: a meta-analysis[J]. Sci Rep, 2017, 7: 42762
[13] Moon SM, Lee DG, Hwang NY, et al. Ipsilateral pleural recurrence after diagnostic transthoracic needle biopsy in pathological stage
Ⅰ lung cancer patients who underwent curative resection[J]. Lung Cancer, 2017, 111: 69-74.
[14] Wisnivesky JP, Henschke CI, Yankelevitz DF. Diagnostic percutaneous transthoracic needle biopsy does not affect survival in stageⅠ lung cancer[J]. Am J Respir Crit Care Med, 2006, 174: 684-688.

相似文献/References:

[1]李任飞,王月东,闫 龑,等.125I粒子植入治疗非小细胞肺癌近期疗效评估[J].介入放射学杂志,2014,(01):65.
 LI Ren? fei,WANG Yue? dong,YAN Yan,et al. Implantation of 125I seeds for the treatment of non?蛳 small cell lung cancer: evaluation of short?蛳 term effect[J].journal interventional radiology,2014,(04):65.
[2]宋晶晶,纪建松,赵中伟,等. 支气管动脉化疗栓塞联合125I粒子植入治疗老年性非小细胞肺癌疗效分析[J].介入放射学杂志,2014,(02):159.
 SONG Jing? jing,JI Jian? song,ZHAO Zhong? wei,et al. Bronchial artery chemoembolization combined with 125I seeds implantation for the treatment of non?蛳 small cell lung cancer in senile patients: comparison with GP chemotherapy scheme[J].journal interventional radiology,2014,(04):159.
[3]赵真真,王忠敏,茅爱武. 非小细胞肺癌的介入治疗现状[J].介入放射学杂志,2014,(03):272.
 ZHAO Zhen? zhen,WANG Zhong? min,MAO Ai? wu.. Current situation of interventional treatment for non?蛳 small cell lung cancer[J].journal interventional radiology,2014,(04):272.
[4]应希慧,纪建松,涂建飞,等.表皮生长因子受体酪氨酸激酶抑制剂联合放射性粒子植入治疗肺癌的疗效分析[J].介入放射学杂志,2015,(03):226.
 YING Xi hui,JI Jian song,TU Jian fei,et al.EGFR TKIS combined with radioactive 125I seed implantation for the treatment of advanced non small cell lung cancer: analysis of clinical effect[J].journal interventional radiology,2015,(04):226.
[5]陆 健,刘 琳,陈志瑾,等.进展期非小细胞肺癌125I粒子植入前后CEA、 CYFRA21- 1变化与临床疗效评估[J].介入放射学杂志,2016,(03):234.
 LU Jian,LIU Lin,CHEN Zhi- jin,et al.The changes of CEA and CYFRA21- 1 levels after 125I seed implantation in advanced non- small cell lung cancer and their correlation with clinical effectiveness[J].journal interventional radiology,2016,(04):234.
[6]刘 亚,吕维富,成德雷,等.静脉化疗联合125I放射性粒子植入治疗中晚期非小细胞肺癌的疗效评价 [J].介入放射学杂志,2018,27(10):966.
 LIU Ya,LV Weifu,CHENG Delei,et al.Efficacy evaluation of intravenous chemotherapy combined with 125I seed implantation in treating advanced non- small cell lung cancer[J].journal interventional radiology,2018,27(04):966.
[7]刘宝东.非小细胞肺癌射频消融热点问题探讨 [J].介入放射学杂志,2018,27(11):1013.
 Discussion on hot issues concerning radiofrequency ablation of non- small cell lung cancer LIU Baodong[J].journal interventional radiology,2018,27(04):1013.
[8]唐钢琴,赵振华,梁晓超.非小细胞肺癌患者射频消融治疗后血清miR-28-3p表达量变化及意义[J].介入放射学杂志,2019,28(09):887.
 TANG Gangqin,ZHAO Zhenhua,LIANG Xiaochao..Changes and significance of serum miRNA-28-3p expression in patients with non-small cell lung cancer after radiofrequency ablation[J].journal interventional radiology,2019,28(04):887.

备注/Memo

备注/Memo:
(收稿日期:2019-06-11)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2020-05-06